PharmaBoardroom

Today, B&M differentiates itself by what it calls its ‘fluency’ in the way you think, work and behave which enables you to navigate…

Dr De Backer looking into your background, we see that you have a background in aerospace engineering and applied biomedical computational fluid…

Dr De Haes, as the CEO of ThromboGenics for the last five years, can you provide us with an overview of the company’s main achievements that you are…

October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the…

October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the…

World Courier's General Manager, Belgium After accumulationg an almost combined five decades of experience at World Courier, can you please tell our…

Mr Noel Foucart, looking into your background, we see that you have accumulated almost 3 decades of experience at World Courier. Can you tell our…

Today, B&M differentiates itself by what it calls its ‘fluency’ in the way you think, work and behave which enables you to navigate…

Can you give our readers a brief overview of Daiichi Sankyo in Austria as well as its market positioning and growth factors in 2012? Daiichi Sankyo…

Dr. Coveney, what motivated you to start this company? I had been working for the multinationals for a number of years—Schering Plough, and a…

What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the strength of Belgium’s clinical trials…

How does the Austrian affiliate fit within Quintiles’ global structure, and what is the scope of the company’s activities here? Quintiles…